Seattle, WA, United States of America

Paul L Weiden

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Paul L. Weiden

Introduction

Paul L. Weiden is a notable inventor based in Seattle, WA, who has made significant contributions to the field of cancer treatment. With a total of four patents to his name, Weiden's work primarily focuses on the use of innovative pharmaceutical methods to combat colorectal cancer.

Latest Patents

One of Weiden's latest patents involves the use of picoplatin, an anti-cancer platinum drug, to treat colorectal cancer. This invention outlines a method of treatment that combines picoplatin with 5-FU and leucovorin in various treatment regimens. The patent details dosages, dosing schedules, and ancillary treatments, showcasing Weiden's commitment to improving cancer therapies.

Career Highlights

Weiden is currently associated with Poniard Pharmaceuticals, Inc., where he continues to develop and refine his innovative approaches to cancer treatment. His work has garnered attention in the medical community, particularly for its potential to enhance patient outcomes in colorectal cancer therapy.

Collaborations

Throughout his career, Weiden has collaborated with esteemed colleagues such as David A. Karlin and Hazel B. Breitz. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Paul L. Weiden's contributions to cancer treatment through his innovative patents highlight his dedication to improving medical therapies. His work continues to inspire advancements in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…